CDK4 is also found to be highly expressed in aggressive tumors and its expression correlate with poor overall and relapse free survival outcomes as well as poor prognostic features of breast cancer patients, suggesting a central role for this protein in cancer development and progression (Massague 2004). This evidence concerns the gene CDK4 and cancer.